Nectin-4 is widely expressed in head and neck squamous cell carcinoma

Oncotarget | Nectin-4 is widely expressed in head and neck squamous cell carcinoma
Nectin-4 immunohistochemistry in HNSCC. Credit: Oncotarget (2022). DOI: 10.18632/oncotarget.28299

Nectin-4 has been successfully established as a target molecule in locally advanced and metastatic bladder cancer. An antibody-drug conjugate (enfortumab-vedotin) directed against nectin-4 has shown marked tumor remission rates in this tumor type, which is known for high expression rates of nectin-4.

As head and neck cancer and urothelial carcinomas share morphological and molecular similarities, researchers Christine Sanders, Jan-Frederic Lau, Dimo Dietrich, Sebastian Strieth, Peter Brossart, and Glen Kristiansen from University Medical Center Bonn and University Hospital Bonn aimed to evaluate Nectin-4 expression in head and neck (HNSCC).

A previously described and clinically characterized cohort of HNSCC (n = 159) was analyzed by immunohistochemistry for Nectin-4 expression. The expression data was correlated to clinico-pathological parameters including patient outcome.

Nectin-4 was found in 86.2% of HNSCC, with medium/high expression seen in 32.7% of cases. Non-smokers and p16 positive HNSCC showed a higher expression of Nectin-4 (p < 0.005). There was no correlation of Nectin-4 with grading or tumor stage. Nectin-4 positive tumors showed significantly better survival (log rank p = 0.006).

"Similar to , Nectin-4 is found in the majority of HNSCC, which clearly warrants further studies to clarify if HNSCC also respond to targeted therapy with enfortumab-vedotin. Moreover, expression of Nectin-4 is associated with HPV infection and may serve as a prognostic marker in HNSCC."

The research was published in Oncotarget.

More information: Christine Sanders et al, Nectin-4 is widely expressed in head and neck squamous cell carcinoma, Oncotarget (2022). DOI: 10.18632/oncotarget.28299

Journal information: Oncotarget
Provided by Impact Journals LLC
Citation: Nectin-4 is widely expressed in head and neck squamous cell carcinoma (2022, November 3) retrieved 14 June 2024 from https://medicalxpress.com/news/2022-11-nectin-widely-neck-squamous-cell.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer

6 shares

Feedback to editors